Tue 1 Dec 2009 | 19:23 EST
You are here: Home > Business & Finance > Stocks > Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSSRSS Feed
Widgets
Mobile
Podcasts
Newsletters
Your View
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters

Officers and Directors For Orexigen Therapeutics, Inc.

Orexigen Therapeutics, Inc. (OREX.O) (Consolidated Issue listed on NASDAQ Global Market)
sector: Healthcare . industry: Pharmaceuticals - Generic & Specialty ยท View OREX on other exchanges
As of  4:00pm EST
7.28USD
Price Change
+0.61
Percent Change
+9.15%
 
Research Another Stock: Symbol Look-up

Name Age Since Current Position
Turner, Heather 36 2007 Vice President, General Counsel, Secretary
Piskorski, Walter 60 2007 Vice President - Technical Operations
Baum, Carol 50 2008 Vice President - Commercialization
Scaife, Michael -- 2009 Senior Vice President - Regulatory Affairs and Product Development, Contrave(R) Program
Hagan, Jay -- 2009 Senior Vice President - Corporate Development and Strategy
Narachi, Michael 50 2009 President, Chief Executive Officer, Director
Bock, Louis 44 2005 Director
Dovey, Brian 67 2004 Director
Lacob, Joseph 53 2004 Director
Powell, Michael 54 2004 Director
Turner, Daniel 47 2005 Director
Mahaffy, Patrick 46 2009 Director
Dunayevich, Eduardo 43 2006 Chief Medical Officer
Cooper, Graham 39 2006 Chief Financial Officer, Treasurer
Booth, Mark -- 2009 Chief Commercial Officer
Weber, Eckard 59 2009 Chairman of the Board